Urine naloxone concentration at different phases of buprenorphine maintenance treatment

In spite of the benefits of buprenorphine‐naloxone co‐formulation (BNX) in opioid maintenance treatment, the naloxone component has not prevented parenteral use of BNX. Current laboratory methods are not sufficient to differentiate between therapeutic and illicit use of buprenorphine, and little is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug testing and analysis 2014-03, Vol.6 (3), p.220-225
Hauptverfasser:	Heikman, Pertti, Häkkinen, Margareeta, Gergov, Merja, Ojanperä, Ilkka
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Buprenorphine - administration & dosage Buprenorphine - analogs & derivatives Buprenorphine - therapeutic use Buprenorphine - urine buprenorphine maintenance treatment Chromatography, Liquid - methods compliance Female Humans Limit of Detection Male Middle Aged naloxone Naloxone - administration & dosage Naloxone - therapeutic use Naloxone - urine Narcotic Antagonists - administration & dosage Narcotic Antagonists - therapeutic use Narcotic Antagonists - urine Narcotics - administration & dosage Narcotics - therapeutic use Narcotics - urine opioid dependence Tandem Mass Spectrometry - methods urine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!